Annual Retained Earnings
-$68.05 M
-$23.96 M-54.35%
December 31, 2023
Summary
- As of February 7, 2025, CNTX annual retained earnings is -$68.05 million, with the most recent change of -$23.96 million (-54.35%) on December 31, 2023.
- During the last 3 years, CNTX annual retained earnings has fallen by -$49.26 million (-262.04%).
- CNTX annual retained earnings is now -262.04% below its all-time high of -$18.80 million, reached on December 31, 2020.
Performance
CNTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$91.44 M
-$17.46 M-23.60%
September 1, 2024
Summary
- As of February 7, 2025, CNTX quarterly retained earnings is -$91.44 million, with the most recent change of -$17.46 million (-23.60%) on September 1, 2024.
- Over the past year, CNTX quarterly retained earnings has dropped by -$17.46 million (-23.60%).
- CNTX quarterly retained earnings is now -386.43% below its all-time high of -$18.80 million, reached on December 31, 2020.
Performance
CNTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CNTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.4% | -23.6% |
| 3 y3 years | -262.0% | -65.0% |
| 5 y5 years | -167.5% | -65.0% |
CNTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -132.6% | at low | -212.6% | at low |
| 5 y | 5-year | -262.0% | at low | -386.4% | at low |
| alltime | all time | -262.0% | at low | -386.4% | at low |
Context Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$91.44 M(+23.6%) |
| Jun 2024 | - | -$73.98 M(+3.1%) |
| Mar 2024 | - | -$71.72 M(+5.4%) |
| Dec 2023 | -$68.05 M(+54.4%) | -$68.05 M(+11.0%) |
| Sep 2023 | - | -$61.28 M(+10.6%) |
| Jun 2023 | - | -$55.41 M(+9.9%) |
| Mar 2023 | - | -$50.40 M(+14.3%) |
| Dec 2022 | -$44.09 M | -$44.09 M(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$40.53 M(+10.5%) |
| Jun 2022 | - | -$36.68 M(+12.2%) |
| Mar 2022 | - | -$32.69 M(+11.8%) |
| Dec 2021 | -$29.25 M(+55.6%) | -$29.25 M(+11.8%) |
| Sep 2021 | - | -$26.16 M(+5.8%) |
| Jun 2021 | - | -$24.72 M(+25.5%) |
| Mar 2021 | - | -$19.69 M(+4.7%) |
| Dec 2020 | -$18.80 M(-26.1%) | -$18.80 M |
| Dec 2019 | -$25.44 M | - |
FAQ
- What is Context Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Context Therapeutics?
- What is Context Therapeutics annual retained earnings year-on-year change?
- What is Context Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Context Therapeutics?
- What is Context Therapeutics quarterly retained earnings year-on-year change?
What is Context Therapeutics annual retained earnings?
The current annual retained earnings of CNTX is -$68.05 M
What is the all time high annual retained earnings for Context Therapeutics?
Context Therapeutics all-time high annual retained earnings is -$18.80 M
What is Context Therapeutics annual retained earnings year-on-year change?
Over the past year, CNTX annual retained earnings has changed by -$23.96 M (-54.35%)
What is Context Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CNTX is -$91.44 M
What is the all time high quarterly retained earnings for Context Therapeutics?
Context Therapeutics all-time high quarterly retained earnings is -$18.80 M
What is Context Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CNTX quarterly retained earnings has changed by -$17.46 M (-23.60%)